Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularization

PURPOSE: To determine the pre-treatment ocular factors significantly associated with the visual outcome 24 months after intravitreal bevacizumab (IVB) for myopic choroidal neovascularization (mCNV). METHODS: A total of 23 eyes of 23 patients with mCNV were treated with IVB followed by as needed ther...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nakanishi, H, Tsujikawa, A, Yodoi, Y, Ojima, Y, Otani, A, Tamura, H, Yamashiro, K, Ooto, S, Yoshimura, N
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2011
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3178312/
https://ncbi.nlm.nih.gov/pubmed/21252956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2010.226
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados